000 01169nam a2200277 a 4500
005 20250914131123.0
008 031002s2003 xxu 001 0 eng b
020 _a1574391623 /c RM261.10
039 9 _a200404150955
_bzaleha
_c200402181107
_dazlan
_c200402181104
_dazlan
_c200402180956
_dazlan
_y10-02-2003
_zdiyana
060 _aQV39
090 _aQV39.H2513h 2003 9HUKM(0009900665)
100 1 _aHansten, Philip D.
245 1 0 _aManaging clinically important drug interactions /
_cPhilip D. Hansten, John R. Horn
246 1 4 _aHansten and Horn managing clinically important drug interactions
260 _aSt. Louis :
_bFacts & Comparisons,
_c2003
300 _axiii, 661 p. ;
_c24 cm.
500 _aAdapted from Hansten and Horn's Drug Interactions Analysis and Management loose-leaf information service through the January 2003 update.
650 2 _aDrug Interactions
_vhandbook
700 1 _aHorn, John R
907 _a.b13273863
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kQV39.H2513h 2003 9HUKM(0009900665)
914 _avtls000341958
991 _aJabatan Farmasi, HUKM
998 _ah
_b2003-02-10
_cm
_da
_feng
_gxxu
_y0
_z.b13273863
999 _c326872
_d326872